Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklaus Schaefer

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Cancers|August 5, 2025
Correction: Cloître et al. Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate-High-Risk Prostate Cancer: Insights from a Phase I/II Study. <i>Cancers</i> 2024, <i>16</i>, 2097Minna Cloître, Sofian Benkhaled, Sarah Boughdad, et al.
EJNMMI Research|June 13, 2019
Internal radiation dosimetry of a <sup>152</sup>Tb-labeled antibody in tumor-bearing miceFrancesco Cicone, Silvano Gnesin, Thibaut Denoël, et al.
Cardiovascular and Interventional Radiology|February 6, 2024
Factors Impacting Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: A Combined Analysis of the Prospective CIRT StudiesPeter Reimer, Valérie Vilgrain, Dirk Arnold, et al.
Cardiovascular and Interventional Radiology|September 25, 2020
Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in FranceRomaric Loffroy, Maxime Ronot, Michel Greget, et al.
Revue Medicale Suisse|December 1, 2021
[Cancer center clinical nurse: The experience of the CHUV Prostate Cancer Center]Caroline Codeluppi, Françoise Ninane, Laura Jolliet, et al.
Neuroendocrinology|July 28, 2020
Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of VariabilityClarisse Dromain, Anders Sundin, Pavan Najran, et al.
The Oncologist|March 27, 2019
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET StudyAngela Lamarca, Joakim Crona, Maxime Ronot, et al.
Swiss Medical Weekly|August 20, 2023
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancerArnoud J Templeton, Aurelius Omlin, Dominik Berthold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2026
Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionalityMaria Ochoa-de-Olza, Nicolas Rayroux, Martina Imbimbo, et al.
Cancer Discovery|September 4, 2021
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to ImmunotherapyFernanda G Herrera, Catherine Ronet, Maria Ochoa de Olza, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Cancers|August 5, 2025
Correction: Cloître et al. Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate-High-Risk Prostate Cancer: Insights from a Phase I/II Study. <i>Cancers</i> 2024, <i>16</i>, 2097Minna Cloître, Sofian Benkhaled, Sarah Boughdad, et al.
EJNMMI Research|June 13, 2019
Internal radiation dosimetry of a <sup>152</sup>Tb-labeled antibody in tumor-bearing miceFrancesco Cicone, Silvano Gnesin, Thibaut Denoël, et al.
Cardiovascular and Interventional Radiology|February 6, 2024
Factors Impacting Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: A Combined Analysis of the Prospective CIRT StudiesPeter Reimer, Valérie Vilgrain, Dirk Arnold, et al.
Cardiovascular and Interventional Radiology|September 25, 2020
Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in FranceRomaric Loffroy, Maxime Ronot, Michel Greget, et al.
Revue Medicale Suisse|December 1, 2021
[Cancer center clinical nurse: The experience of the CHUV Prostate Cancer Center]Caroline Codeluppi, Françoise Ninane, Laura Jolliet, et al.
Neuroendocrinology|July 28, 2020
Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of VariabilityClarisse Dromain, Anders Sundin, Pavan Najran, et al.
The Oncologist|March 27, 2019
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET StudyAngela Lamarca, Joakim Crona, Maxime Ronot, et al.
Swiss Medical Weekly|August 20, 2023
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancerArnoud J Templeton, Aurelius Omlin, Dominik Berthold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2026
Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionalityMaria Ochoa-de-Olza, Nicolas Rayroux, Martina Imbimbo, et al.
Cancer Discovery|September 4, 2021
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to ImmunotherapyFernanda G Herrera, Catherine Ronet, Maria Ochoa de Olza, et al.
Pageof 11